Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK778 vs MMF with Prograf in De Novo Kidney Transplant
NCT00282230Phase 2Terminated
- Sponsor
- Astellas Pharma
- Start
- Nov 2003
- Countries
- 1
01
Overview
A Phase 2 trial of manitimus in kidney transplant rejection, sponsored by Astellas Pharma. Started Nov 2003; status: terminated.
02
Drugs
manitimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00282230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282230.